RBC Capital maintains Oracle stock rating, citing OCI growth questions

Published 09/09/2025, 10:34
RBC Capital maintains Oracle stock rating, citing OCI growth questions

Investing.com - RBC Capital has reiterated its Sector Perform rating for Oracle (NYSE:ORCL), a $670 billion market cap software giant, with a price target of $195.00 ahead of the company’s fiscal first-quarter 2026 results. According to InvestingPro analysis, Oracle is currently trading above its Fair Value, with the stock showing a remarkable 72% return over the past year.

The research firm noted that investor attention is primarily focused on whether Oracle’s Cloud Infrastructure (OCI) can exceed the expected low-50s year-over-year growth rate, and how much of the $30 billion OpenAI contract represents incremental business. With annual revenue of $57.4 billion and a robust gross profit margin of 70.5%, Oracle maintains its position as a prominent player in the software industry. For deeper insights into Oracle’s growth metrics and 14+ additional ProTips, check out InvestingPro.

RBC Capital also highlighted questions about whether Oracle’s Stargate technology has begun contributing to the company’s financial results, with the timing of its impact remaining uncertain.

The firm anticipates solid OCI growth and a potential increase in Remaining Performance Obligations (RPO) connected to large AI contracts, though it maintains that disclosures on these key areas will likely determine market reaction following the earnings report.

RBC’s maintained price target of $195 implies a calendar year 2026 price-to-earnings multiple of 38x, compared to the current 46.8x multiple, following Oracle’s stock appreciation of more than 70% over the past year.

In other recent news, Oracle has been at the center of several significant developments. The company is preparing to release its first-quarter earnings report, with TD Cowen expecting a 10% growth in constant currency, highlighting strong demand for Oracle Cloud Infrastructure. Morgan Stanley has raised its price target for Oracle to $246, maintaining an Equalweight rating, while Global Equities Research increased its target to $400, citing Oracle’s pivotal role in the evolving technology landscape. Additionally, Oracle’s data centers in Wisconsin and Texas are set to receive a $38 billion debt package led by JPMorgan Chase and Mitsubishi UFJ Financial Group, which includes a $23 billion loan for the Texas campus. NYC Health + Hospitals has announced it will adopt Oracle Fusion Cloud Applications to enhance its operational efficiency across finance, supply chain, and human resources. These developments underscore Oracle’s continued influence in the tech industry and its strategic advancements in cloud infrastructure and applications.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.